Professor Piotr Popik, dr hab.

Professor Piotr Popik, dr hab.
Achievements
- Publications
Serotonin transporter deficiency alters socioemotional ultrasonic communication in rats
Autorzy:
DOI: 10.1038/s41598-019-56629-y
Date: 2019-12-01
Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties.
Autorzy:
DOI: 10.1016/j.ejmech.2019.111857
Date: 2019-11-07
Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats
Autorzy: Piotr Popik, Martyna Krawczyk, Agata Kuziak, Ryszard Bugno, Adam Hogendorf, Jakub Staroń, Agnieszka Nikiforuk
DOI: 10.1177/0269881119867603
Date: 2019-11-01
2-Aminoimidazole-based antagonists of the 5-HT6 receptor – A new concept in aminergic GPCR ligand design
Autorzy:
DOI: 10.1016/j.ejmech.2019.06.001
Date: 2019-10-01
Dopamine D2/D3 receptor agonists attenuate PTSD-like symptoms in mice exposed to single prolonged stress
Autorzy: Natalia Malikowska-Racia, Kinga Sałat, Alicja Nowaczyk, Łukasz Fijałkowski, Piotr Popik
DOI: 10.1016/j.neuropharm.2019.05.012
Date: 2019-09-01
Dual 5-HT6 and D3 Receptor Antagonists in a Group of 1H-Pyrrolo[3,2-c]quinolines with Neuroprotective and Procognitive Activity
Autorzy:
DOI: 10.1021/acschemneuro.8b00618
Date: 2019-07-17
Evaluation of ultrasonic vocalizations in a neurodevelopmental model of schizophrenia during the early life stages of rats
Autorzy:
DOI: 10.1016/j.neuropharm.2018.11.023
Date: 2019-03-01
Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α7-nicotinic acetylcholine receptors
Autorzy:
DOI: 10.1177/0269881118812097
Date: 2019-01-01
Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects.
Autorzy: Zajdel P, Kos T, Marciniec K, Satała G, Canale V, Kamiński K, Hołuj M, Lenda T, Koralewski R, Bednarski M, Nowiński L, Wójcikowski J, Daniel WA, Popik P
DOI: 10.1016/j.ejmech.2018.01.002
Date: 2018-01-01
Novel non-sulfonamide 5-HT6 receptor partial inverse agonist in a group of imidazo[4,5-b]pyridines with cognition enhancing properties.
Autorzy: Vanda D, Soural M, Canale V, Chaumont-Dubel S, Satała G, Kos T, Funk P, Fülöpová V, Lemrová B, Koczurkiewicz P, Pękala E, Bojarski AJ, Popik P, Marin P, Zajdel P
DOI: 10.1016/j.ejmech.2017.12.053
Date: 2017-12-01